Girard Partners’s Exelixis EXEL Stock Holding History

Girard Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$3K	–	413
2018 Q3	$3K	Buy	+200	New	+$3.9K	﹤0.01%	874

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Girard Partners's EXEL Position: Q4 2018 in Review

Girard Partners sold out of Exelixis (EXEL) in Q4 2018, closing a stake of 200 shares — an estimated $3K sold.

Girard Partners first reported a position in EXEL in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 344 funds tracked by Wall St. Rank hold EXEL as of Q4 2018.

Girard Partners reported no remaining Exelixis position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 200 Exelixis shares in Q4 2018, an estimated $3K.
Girard Partners first reported a position in Exelixis in Q3 2018 and held it in 1 quarter.
Girard Partners's Exelixis position peaked at $3K in Q3 2018.
344 funds tracked by Wall St. Rank held Exelixis as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.